These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 7989896)

  • 1. Homocyst(e)ine and arterial occlusive diseases.
    Malinow MR
    J Intern Med; 1994 Dec; 236(6):603-17. PubMed ID: 7989896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma homocyst(e)ine: a risk factor for arterial occlusive diseases.
    Malinow MR
    J Nutr; 1996 Apr; 126(4 Suppl):1238S-43S. PubMed ID: 8642463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma homocyst(e)ine and arterial occlusive diseases: a mini-review.
    Malinow MR
    Clin Chem; 1995 Jan; 41(1):173-6. PubMed ID: 7813076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between high homocyst(e)ine and ischemic stroke due to large- and small-artery disease but not other etiologic subtypes of ischemic stroke.
    Eikelboom JW; Hankey GJ; Anand SS; Lofthouse E; Staples N; Baker RI
    Stroke; 2000 May; 31(5):1069-75. PubMed ID: 10797167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The association of elevated plasma homocyst(e)ine with progression of symptomatic peripheral arterial disease.
    Taylor LM; DeFrang RD; Harris EJ; Porter JM
    J Vasc Surg; 1991 Jan; 13(1):128-36. PubMed ID: 1987384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated plasma homocyst(e)ine concentration as a possible independent risk factor for stroke.
    Coull BM; Malinow MR; Beamer N; Sexton G; Nordt F; de Garmo P
    Stroke; 1990 Apr; 21(4):572-6. PubMed ID: 2326839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of plasma homocyst(e)ine in arterial occlusive diseases.
    Malinow MR; Stampfer MJ
    Clin Chem; 1994 Jun; 40(6):857-8. PubMed ID: 8087977
    [No Abstract]   [Full Text] [Related]  

  • 8. Homocysteine metabolism and risk of myocardial infarction: relation with vitamins B6, B12, and folate.
    Verhoef P; Stampfer MJ; Buring JE; Gaziano JM; Allen RH; Stabler SP; Reynolds RD; Kok FJ; Hennekens CH; Willett WC
    Am J Epidemiol; 1996 May; 143(9):845-59. PubMed ID: 8610698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patients with atherosclerotic vascular disease: how low should plasma homocyst(e)ine levels go?
    Spence JD
    Am J Cardiovasc Drugs; 2001; 1(2):85-9. PubMed ID: 14728038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction of plasma homocyst(e)ine levels by breakfast cereal fortified with folic acid in patients with coronary heart disease.
    Malinow MR; Duell PB; Hess DL; Anderson PH; Kruger WD; Phillipson BE; Gluckman RA; Block PC; Upson BM
    N Engl J Med; 1998 Apr; 338(15):1009-15. PubMed ID: 9535664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Homocyst(e)ine and cardiovascular disease: a critical review of the epidemiologic evidence.
    Eikelboom JW; Lonn E; Genest J; Hankey G; Yusuf S
    Ann Intern Med; 1999 Sep; 131(5):363-75. PubMed ID: 10475890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hyperhomocyst(e)inemia--an independent risk factor of stroke].
    Lalouschek W; Aull S; Deecke L; Schnider P; Uhl F; Zeiler K
    Fortschr Neurol Psychiatr; 1996 Jul; 64(7):271-7. PubMed ID: 8765893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of hyperhomocyst(e)inemia in patients with peripheral arterial occlusive disease.
    Malinow MR; Kang SS; Taylor LM; Wong PW; Coull B; Inahara T; Mukerjee D; Sexton G; Upson B
    Circulation; 1989 Jun; 79(6):1180-8. PubMed ID: 2785871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of growth hormone (GH) administration on homocyst(e)ine levels in men with GH deficiency: a randomized controlled trial.
    Sesmilo G; Biller BM; Llevadot J; Hayden D; Hanson G; Rifai N; Klibanski A
    J Clin Endocrinol Metab; 2001 Apr; 86(4):1518-24. PubMed ID: 11297577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Homocyst(e)ine and coronary heart disease: pharmacoeconomic support for interventions to lower hyperhomocyst(e)inaemia.
    Nallamothu BK; Fendrick AM; Omenn GS
    Pharmacoeconomics; 2002; 20(7):429-42. PubMed ID: 12093299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Homocyst(e)ine: an important risk factor for atherosclerotic vascular disease.
    Duell PB; Malinow MR
    Curr Opin Lipidol; 1997 Feb; 8(1):28-34. PubMed ID: 9127708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma homocyst(e)ine levels and graded risk for myocardial infarction: findings in two populations at contrasting risk for coronary heart disease.
    Malinow MR; Ducimetiere P; Luc G; Evans AE; Arveiler D; Cambien F; Upson BM
    Atherosclerosis; 1996 Sep; 126(1):27-34. PubMed ID: 8879431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective study of plasma homocyst(e)ine and risk of ischemic stroke.
    Verhoef P; Hennekens CH; Malinow MR; Kok FJ; Willett WC; Stampfer MJ
    Stroke; 1994 Oct; 25(10):1924-30. PubMed ID: 8091435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short-term folic acid supplementation induces variable and paradoxical changes in plasma homocyst(e)ine concentrations.
    Malinow MR; Duell PB; Williams MA; Kruger WD; Evans AA; Anderson PH; Block PC; Hess DL; Upson BM; Graf EE; Irvin-Jones A; Wang L
    Lipids; 2001; 36 Suppl():S27-32. PubMed ID: 11837988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carotid artery intimal-medial wall thickening and plasma homocyst(e)ine in asymptomatic adults. The Atherosclerosis Risk in Communities Study.
    Malinow MR; Nieto FJ; Szklo M; Chambless LE; Bond G
    Circulation; 1993 Apr; 87(4):1107-13. PubMed ID: 8462139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.